IL108837A - Interleukin Purification - 10 Human - Google Patents

Interleukin Purification - 10 Human

Info

Publication number
IL108837A
IL108837A IL10883794A IL10883794A IL108837A IL 108837 A IL108837 A IL 108837A IL 10883794 A IL10883794 A IL 10883794A IL 10883794 A IL10883794 A IL 10883794A IL 108837 A IL108837 A IL 108837A
Authority
IL
Israel
Prior art keywords
protein
fractions
dimers
column
hydroxyapatite
Prior art date
Application number
IL10883794A
Other languages
English (en)
Hebrew (he)
Other versions
IL108837A0 (en
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL108837A0 publication Critical patent/IL108837A0/xx
Publication of IL108837A publication Critical patent/IL108837A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5428IL-10
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL10883794A 1993-03-05 1994-03-03 Interleukin Purification - 10 Human IL108837A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/026,942 US5328989A (en) 1993-03-05 1993-03-05 Purification of human interleukin-10 from a cell culture medium

Publications (2)

Publication Number Publication Date
IL108837A0 IL108837A0 (en) 1994-06-24
IL108837A true IL108837A (en) 2001-01-11

Family

ID=21834690

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10883794A IL108837A (en) 1993-03-05 1994-03-03 Interleukin Purification - 10 Human

Country Status (12)

Country Link
US (2) US5328989A (hu)
EP (1) EP0688335A1 (hu)
JP (1) JP2802168B2 (hu)
KR (1) KR0178304B1 (hu)
CN (1) CN1119018A (hu)
AU (1) AU683458B2 (hu)
CA (1) CA2157358C (hu)
FI (1) FI954047A (hu)
HU (1) HU218263B (hu)
IL (1) IL108837A (hu)
NZ (1) NZ263006A (hu)
WO (1) WO1994020525A1 (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106823A (en) * 1991-01-16 2000-08-22 Schering Corporation Treatment of neoplastic disease with interleukin-10
US5328989A (en) * 1993-03-05 1994-07-12 Schering-Plough Purification of human interleukin-10 from a cell culture medium
CA2144576A1 (en) * 1994-03-17 1995-09-18 Donald W. Nicholson A single step purification of recombinant human interleukin-5
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
US7361331B2 (en) * 1996-10-18 2008-04-22 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Plant bioreactors
JP4346116B2 (ja) * 1997-10-14 2009-10-21 中外製薬株式会社 リンパ球系腫瘍に対する抗体の作用増強剤
JP2003535565A (ja) * 1998-12-31 2003-12-02 アーチ ディベロプメント コーポレイション 新生物疾患の治療に有用な組換え単純ヘルペスウイルス
AU6347100A (en) * 1999-07-16 2001-02-05 Human Genome Sciences, Inc. Real-time, in situ biomanufacturing process monitoring and control in response to ir spectroscopy
JP2003508185A (ja) * 1999-08-03 2003-03-04 スミス アンド ネフュー インコーポレーテッド 埋め込み型制御放出装置
CN1370076A (zh) * 1999-08-23 2002-09-18 中外制药株式会社 Hm1.24抗原的表达增强剂
JP3986439B2 (ja) * 2001-02-07 2007-10-03 中外製薬株式会社 造血器腫瘍の治療剤
US20050152902A1 (en) * 2001-06-05 2005-07-14 Advanced Biotherapy, Inc. Treatment of diabetic retinopathy
JP5525118B2 (ja) 2002-09-11 2014-06-18 中外製薬株式会社 タンパク質精製方法
US20050276807A1 (en) * 2004-06-15 2005-12-15 Advanced Biotherapy, Inc. Treatment of acne
US20140228539A1 (en) * 2011-10-21 2014-08-14 Tanvex Biologics Corp. Separation of acetylated proteins from unacetylated proteins
WO2013058762A1 (en) * 2011-10-21 2013-04-25 Tanvex Biologics Corp. Separation of acetylated proteins from unacetylated proteins
CN103360461B (zh) * 2012-03-31 2016-12-14 中国科学技术大学 一种人il-12亲和纯化层析柱、其制备方法及利用其纯化重组人il-12的方法
BR112015026122A8 (pt) 2013-04-18 2020-01-21 Armo Biosciences Inc agente de polietileno glicol-il-10 (peg-il-10), seu uso, composição farmacêutica, contentor estéril e kit
US9823255B2 (en) 2013-06-17 2017-11-21 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
US11413332B2 (en) 2013-11-11 2022-08-16 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
WO2016064817A1 (en) 2014-10-22 2016-04-28 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
AU2016268403A1 (en) 2015-05-28 2017-12-07 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
EP3341012A4 (en) 2015-08-25 2019-03-20 Armo Biosciences, Inc. METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
CN106222222B (zh) * 2016-08-08 2019-10-29 湖北医药学院 一种重组人白血病抑制因子的制备方法
WO2021034727A1 (en) * 2019-08-16 2021-02-25 Applied Molecular Transport Inc. Compositions, formulations, and interleukin production and purification
CN112501126B (zh) * 2020-12-03 2023-04-07 康立泰生物医药(青岛)有限公司 一种cho-dhfr+细胞株及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110611A1 (de) * 1981-03-18 1982-10-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "mitogene der leukozyten und des entzuendungsgewebes:natuerliche leukopoetine zur selektiven anregung der teilung und differenzierung von leukozyten"
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4751078A (en) * 1985-07-03 1988-06-14 Nagabhushan Tattanahalli L Process for the purification of gamma interferon
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
US5227302A (en) * 1988-12-20 1993-07-13 Ludwig Institute For Cancer Research DNA encoding platelet derived endothelial cell growth factor (PD-ECGF)
US5055555A (en) * 1989-01-05 1991-10-08 Helmut Sassenfeld Purification of G-CSF
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
US5368854A (en) * 1992-08-20 1994-11-29 Schering Corporation Use of IL-10 to treat inflammatory bowel disease
US5328989A (en) * 1993-03-05 1994-07-12 Schering-Plough Purification of human interleukin-10 from a cell culture medium

Also Published As

Publication number Publication date
JP2802168B2 (ja) 1998-09-24
IL108837A0 (en) 1994-06-24
US5328989A (en) 1994-07-12
HUT73102A (en) 1996-06-28
CN1119018A (zh) 1996-03-20
AU683458B2 (en) 1997-11-13
CA2157358C (en) 2000-05-16
KR0178304B1 (ko) 1999-04-01
CA2157358A1 (en) 1994-09-15
AU6351594A (en) 1994-09-26
WO1994020525A1 (en) 1994-09-15
NZ263006A (en) 1997-07-27
FI954047A0 (fi) 1995-08-29
HU218263B (hu) 2000-06-28
JPH08503227A (ja) 1996-04-09
US5710251A (en) 1998-01-20
HU9502586D0 (en) 1995-10-30
EP0688335A1 (en) 1995-12-27
FI954047A (fi) 1995-08-29
KR960701084A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
CA2157358C (en) Purification of human interleukin-10
EP1931704B1 (en) Production and purification of il-29
JP4317890B2 (ja) 疎水性ポリペプチドの細菌生産
AU610182B2 (en) Production of purified, biologically active, bacterially produced recombinant human csf-1
WO2004055168A2 (en) Il-21 production in prokaryotic hosts
US20080171857A1 (en) Process for the Purification of Recombinant Granulocyte-Colony Stimulating Factor
EP0618220B1 (en) Method for purifying interleukin-4
EP1656455B1 (en) Process for the purification of recombinant polypeptides
Cannon-Carlson et al. Expression, purification, and characterization of recombinant human interleukin-13 from NS-0 cells
KR101858598B1 (ko) 인터페론 알파 5의 제조방법
JP2000512143A (ja) 組換え大腸菌からのヒト・インターロイキン1レセプター・拮抗薬の精製方法
WO1997048808A1 (en) Bacterial production of interferon-beta using low levels of sodium and potassium ions
IL120009A (en) Method for production of interferon - ?? polypeptide in a host cell
IE75354B1 (en) Method for purifying interleukin-4
NZ214261A (en) Human immune interferon: production by recombinant dna technology

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed